News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
113,117 Results
Type
Article (7496)
Company Profile (28)
Press Release (105593)
Section
Business (33525)
Career Advice (229)
Deals (5287)
Drug Delivery (11)
Drug Development (10085)
Employer Resources (14)
FDA (3339)
Job Trends (3240)
News (54513)
Policy (5951)
Tag
Academia (740)
Alliances (10562)
Alzheimer's disease (228)
Antibody-drug conjugate (ADC) (17)
Approvals (3357)
Artificial intelligence (32)
Bankruptcy (32)
Best Places to Work (2530)
Biotechnology (20)
Breast cancer (36)
Cancer (256)
Cardiovascular disease (19)
Career advice (211)
Cell therapy (41)
Clinical research (7573)
Collaboration (123)
COVID-19 (697)
Cystic fibrosis (20)
Data (252)
Diagnostics (3171)
Drug discovery (18)
Earnings (9788)
Events (11801)
Executive appointments (62)
FDA (3435)
Funding (68)
Gene therapy (27)
GLP-1 (117)
Government (1007)
Healthcare (2746)
Infectious disease (714)
Interviews (32)
IPO (1669)
Job creations (835)
Job search strategy (196)
Layoffs (41)
Legal (1204)
Lung cancer (43)
Lymphoma (19)
Manufacturing (50)
Medical device (1836)
Medtech (1837)
Mergers & acquisitions (3640)
Metabolic disorders (41)
Neuroscience (265)
NextGen Class of 2024 (985)
Non-profit (660)
Northern California (210)
Obesity (22)
Opinion (32)
People (9948)
Phase I (2280)
Phase II (2995)
Phase III (2889)
Pipeline (69)
Postmarket research (412)
Preclinical (1305)
Press Release (18)
Radiopharmaceuticals (34)
Rare diseases (38)
Real estate (2037)
Regulatory (3997)
Research institute (682)
Resumes & cover letters (24)
Southern California (178)
Startups (671)
United States (2088)
Vaccines (62)
Date
Last 7 days (43)
Last 30 days (346)
Last 365 days (5205)
2024 (5192)
2023 (5931)
2022 (9603)
2021 (10070)
2020 (9774)
2019 (7029)
2018 (5491)
2017 (5689)
2016 (5855)
2015 (6447)
2014 (5144)
2013 (4507)
2012 (4847)
2011 (4912)
2010 (4282)
Location
Africa (142)
Arizona (28)
Asia (7018)
Australia (1132)
California (466)
Canada (223)
China (27)
Colorado (24)
Connecticut (22)
Delaware (19)
Europe (15173)
Florida (67)
Illinois (39)
Indiana (32)
Japan (22)
Kansas (20)
Maine (21)
Maryland (82)
Massachusetts (321)
Michigan (60)
Minnesota (32)
New Jersey (204)
New York (169)
North Carolina (123)
Northern California (210)
Ohio (28)
Pennsylvania (79)
South America (197)
Southern California (178)
Texas (115)
Utah (27)
Washington State (61)
113,117 Results for "seventh wave laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Huntington’s disease
Takeda Walks Away From Wave Huntington’s Partnership After Sinking $260M in Collaboration
Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on Wave’s WVE-003 clinical-stage Huntington’s disease program—a potential $5 billion commercial opportunity, according to the biotech.
October 16, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Lilly announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase
December 10, 2024
·
3 min read
Press Releases
Wave Life Sciences to Present at Upcoming Investor Conferences
November 26, 2024
·
1 min read
Series B
Adcendo Rides ADC Wave With $135M Series B
Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.
November 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 16, 2024
·
1 min read
Press Releases
Wave Life Sciences to Present at Jefferies London Healthcare Conference
November 15, 2024
·
1 min read
Press Releases
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
December 16, 2024
·
5 min read
Press Releases
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
December 23, 2024
·
5 min read
Press Releases
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
September 24, 2024
·
5 min read
Drug Development
Wave Clears Phase Ib/IIa Study in Huntington’s Disease, Eyes Accelerated Approval
After back-to-back failures in 2021, Wave Life Sciences has finally aced a Phase Ib/IIa Huntington’s disease trial and is looking to a potential accelerated approval for its investigational antisense oligonucleotide.
June 26, 2024
·
2 min read
·
Tristan Manalac
1 of 11,312
Next
